DexCom Inc.

DexCom Inc. leads the global CGM market with G6 & G7 systems, a real‑time API, and Stelo OTC biosensor, driving growth through expansion into remote monitoring and digital health integration.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Medical Equipment Manufacturing

Employees: 10,200
HQ: San Diego

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
DXCM	DexCom Inc. Cap: 28.6B \| P/E: 40.5	EQUITY	NMS	USD	US2521311074	Active	📈